Cardlytics Inc (CDLX) stock analysis: A comprehensive overview

While Cardlytics Inc has overperformed by 20.83%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CDLX fell by -45.28%, with highs and lows ranging from $9.48 to $1.22, whereas the simple moving average fell by -25.94% in the last 200 days.

On October 11, 2024, Evercore ISI started tracking Cardlytics Inc (NASDAQ: CDLX) recommending In-line. A report published by Northland Capital on August 16, 2024, Downgraded its rating to ‘Market Perform’ for CDLX. BofA Securities also Downgraded CDLX shares as ‘Underperform’, setting a target price of $3.50 on the company’s shares in a report dated August 15, 2024. Lake Street August 08, 2024d its ‘Buy’ rating to ‘Hold’ for CDLX, as published in its report on August 08, 2024. BofA Securities also rated the stock as ‘Neutral’.

Analysis of Cardlytics Inc (CDLX)

Further, the quarter-over-quarter decrease in sales is -8.45%, showing a negative trend in the upcoming months.

Cardlytics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -135.48% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.19, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and CDLX has an average volume of 968.76K. On a monthly basis, the volatility of the stock is set at 9.17%, whereas on a weekly basis, it is put at 9.63%, with a gain of 13.41% over the past seven days. Furthermore, long-term investors anticipate a median target price of $2.54, showing growth from the present price of $2.03, which can serve as yet another indication of whether CDLX is worth investing in or should be passed over.

How Do You Analyze Cardlytics Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 5.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 54.57% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

CDLX shares are owned by institutional investors to the tune of 54.57% at present.

Hot this week

How to interpret Mira Pharmaceuticals Inc (MIRA)’s stock chart patterns

While Mira Pharmaceuticals Inc has overperformed by 4.17%, investors...

ImmunityBio Inc (IBRX) stock on the rise: An overview

While ImmunityBio Inc has overperformed by 1.12%, investors are...

What technical indicators reveal about NRIX stock

Within its last year performance, NRIX fell by -40.29%,...

Canopy Growth Corporation (CGC) stock analysis: A simple moving average approach

While Canopy Growth Corporation has overperformed by 11.61%, investors...

Venture Global Inc (VG)’s highs and lows: A closer look at its stock price fluctuations

While Venture Global Inc has underperformed by -0.73%, investors...

Topics

How to interpret Mira Pharmaceuticals Inc (MIRA)’s stock chart patterns

While Mira Pharmaceuticals Inc has overperformed by 4.17%, investors...

ImmunityBio Inc (IBRX) stock on the rise: An overview

While ImmunityBio Inc has overperformed by 1.12%, investors are...

What technical indicators reveal about NRIX stock

Within its last year performance, NRIX fell by -40.29%,...

Canopy Growth Corporation (CGC) stock analysis: A simple moving average approach

While Canopy Growth Corporation has overperformed by 11.61%, investors...

Venture Global Inc (VG)’s highs and lows: A closer look at its stock price fluctuations

While Venture Global Inc has underperformed by -0.73%, investors...

A year in review: Innodata Inc (INOD)’s performance in the last year

While Innodata Inc has underperformed by -2.74%, investors are...

OSCR overperforms with a 7.93 increase in share price

While Oscar Health Inc has overperformed by 7.93%, investors...

Technical analysis of Outlook Therapeutics Inc (OTLK) stock chart patterns

While Outlook Therapeutics Inc has overperformed by 0.97%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.